Dr Andrew Eichholz was awarded the iWantGreatCare certificate of excellence in 2024 for delivering outstanding care.

 

Reviews

 
Recommend
Trust
Listening
 
Page 30 of 43
 
Written by a patient at The Churchill
14th May 2019


He listened and responded to my concerns in a friendly and reassuring way.

Recommend
Trust
Listening
 
Written by a patient at The Churchill
9th April 2019


I found Dr Eichholz to be very courteous , patient and thorough. He listened attentively to my concerns about my symptoms , and was very willing to refer me for a series of scans. He was very efficient and gave me a date for a follow-up appointment during my time with him ,which I found very re-assuring. Fortunately my cancer had not returned and he suggested that I contact my GP for further investigation.

Recommend
Trust
Listening
 
Written by a patient at Stoke Mandeville Hospital
5th April 2019


I found him very approachable and very clear about the choice of treatments available after surgery.

Recommend
Trust
Listening
 
Written by a patient at The Churchill
29th March 2019


I have been under the care of Dr.Eichholz since early 2018. He is simply wonderful. At my appointments, he has taken the time to explain my treatment, and possible side effects and has listened to what I have had to say. I have always looked forward to seeing him, - he is genuinely friendly, warm and reassuring, and I could not have wished for a better oncologist. He- and all the staff at the Churchill- are first class, and I will be forever grateful to them for all they have done for me.

Recommend
Trust
Listening
 
Written by a patient at Stoke Mandeville Hospital
20th March 2019


Very friendly Clear explanations Had sent useful info before the appt

Recommend
Trust
Listening
 
 

Page 30 of 43

Specialises in

  • Oncology

Profile

I am a Consultant Clinical Oncologist. I specialise in looking after patients with breast cancer.

I use chemotherapy, hormonal therapy, immunotherapy and the newer biological (also known as targeted) therapies. I also offer entry into any suitable clinical trials of new treatments.